Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
XinVivo
AddedFeb 17, 2024
UpdatedJun 18, 2026
XinVivo

XinVivo

XinVivo: A nanotech firm specializing in medical devices and 3D scanning technology.

HQ
Morrisville, NC, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with a vision to revolutionize medical imaging, XinVivo is a nanotechnology firm specializing in advanced medical devices and 3D scanning technology. The company aims to enhance diagnostic accuracy and patient outcomes through its innovative solutions. XinVivo's flagship product, Portray 3D Tomosynthesis, generates high-resolution, volumetric images that allow medical professionals to examine intricate details, particularly in dental applications such as general dentistry, periodontics, and endodontics.

XinVivo has garnered attention from notable figures in the medical and tech industries, contributing to its credibility and growth. The company boasts an advisory board of esteemed experts who guide its technological advancements. Key achievements include the successful deployment of Portray 3D Tomosynthesis in various dental practices, significantly improving diagnostic certainty and treatment planning. XinVivo's impact is evident in its ability to provide more precise imaging solutions, setting new standards in medical diagnostics.

XinVivo - Similar Companies

Surround Medical Systems logo

Surround Medical Systems

portrayxray.com

Xoran Technologies logo

Xoran Technologies

xorantech.com

X-Nav Technologies logo

X-Nav Technologies

x-navtech.com

Asvin Tech logo

Asvin Tech

dentratech.com

Precision Through Imaging logo

Precision Through Imaging

Lantos Technologies logo

Lantos Technologies

NexRay logo

NexRay

Visie logo

Visie

visievision.com

Clarix Imaging logo

Clarix Imaging

clariximaging.com

Exo logo

Exo

exo.inc

Scinovia logo

Scinovia

Livivos logo

Livivos

livivos.com

XN Health logo

XN Health

xn-health.com

VenX logo

VenX

Vitrix Health logo

Vitrix Health

XinVivo - Quick Facts

Who are XinVivo's competitors?

Companies similar to XinVivo include Surround Medical Systems, Xoran Technologies, X-Nav Technologies and Asvin Tech.

When was XinVivo founded?

XinVivo was founded in 2015.

Where is XinVivo's headquarters located?

XinVivo's headquarters is located in Morrisville, NC, US.

When was XinVivo's last funding round?

XinVivo's most recent funding round was for $25.3M (USD) in August 2019.

How much has XinVivo raised to-date?

As of Aug 29, 2019, XinVivo has raised a total of $25.3M (USD).

How many employees does XinVivo have?

XinVivo has 30 employees as of Feb 4, 2024.

XinVivo - Classification

Industry
  • Hardware
Ownership
  • Private
Geographic Exposure
  • Americas
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • 3D Scanning
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified